1. |
Wong J, Abrishami A, EI Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg (Am), 2010, 92(15): 2503-2513.
|
2. |
Nielsen CS, Jans Ø, Ørsnes T, et al. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg (Am), 2016, 98(10): 835-841.
|
3. |
Yuan X, Li B, Wang Q, et al. Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: A prospective, randomized, controlled study. J Arthroplasty, 2017, 32(9): 2738-2743.
|
4. |
Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta, 1981, 673(1): 75-85.
|
5. |
Boese CK, Centeno L, Walters RW. Blood conservation using tranexamic acid is not superior to epsilon-aminocaproic acid after total knee arthroplasty. J Bone Joint Surg (Am), 2017, 99(19): 1621-1628.
|
6. |
Stowers MDJ, Aoina J, Vane A, et al. Tranexamic acid in knee surgery study-A multicentered, randomized, controlled trial. J Arthroplasty, 2017, 32(11): 3379-3384.
|
7. |
李锐博, 尹诗九, 钟航, 等. 静脉联合关节腔内注射氨甲环酸后引流管夹闭时间对人工全膝关节置换术后失血量的影响及安全性评价. 中国修复重建外科杂志, 2017, 31(4): 417-421.
|
8. |
Franchini M, Mengoli C, Marietta M, et al. Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus, 2018, 16(1): 36-43.
|
9. |
Liu X, Liu J, Sun G. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis. Int J Surg, 2017, 41: 34-43.
|
10. |
Zhang P, Li JF, Wang X. Combined versus single application of tranexamic acid in total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. Int J Surg, 2017, 43: 171-180.
|
11. |
Xie J, Ma J, Yue C, et al. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int, 2016, 26(1): 36-42.
|
12. |
Lin SY, Chen CH, Fu YC, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty, 2015, 30(5): 776-780.
|
13. |
Kim YH, Pandey K, Park JW, et al. Comparative efficacy of intravenous with intra-articular versus intravenous only administration of tranexamic acid to reduce blood loss in knee arthroplasty. Orthopedics, 2018, 17: 1-4.
|
14. |
Xiong H, Liu Y, Zeng Y, et al. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord, 2018, 19(1): 321.
|
15. |
Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The efficacy of tranexamic acid in total hip arthroplasty: A network meta-analysis. J Arthroplasty, 2018, 33(10): 3083-3089.
|
16. |
周宗科, 翁习生, 曲铁兵, 等. 中国髋、膝关节置换术加速康复——围术期管理策略专家共识. 中华骨与关节外科杂志, 2016, 9(1): 1-9.
|
17. |
中华医学会骨科学分会. 预防骨科大手术深静脉血栓形成指南(草案). 中国矫形外科杂志, 2009, 17(2): 118-119.
|
18. |
岳辰, 周宗科, 裴福兴, 等. 中国髋、膝关节置换术围术期抗纤溶药序贯抗凝血药应用方案的专家共识. 中华骨与关节外科杂志, 2015, 8(4): 281-285.
|
19. |
李林涛, 吴海山, 吴宇黎, 等. 人工关节置换术围手术期的血液管理策略. 中国修复重建外科杂志, 2015, 29(6): 772-776.
|
20. |
White CC 4th, Eichinger JK, Friedman RJ. Minimizing blood loss and transfusions in total knee arthroplasty. J Knee Surg, 2018, 31(7): 594-599.
|
21. |
Fransen BL, Hoozemans MJM, Argelo KDS, et al. Fast-track total knee arthroplasty improved clinical and functional outcome in the first 7 days after surgery: a randomized controlled pilot study with 5-year follow-up. Arch Orthop Trauma Surg, 2018, 138(9): 1305-1316.
|
22. |
Huang Z, Xie X, Li L, et al. Intravenous and topical tranexamic acid alone are superior to tourniquet use for primary total knee arthroplasty: A prospective, randomized controlled trial. J Bone Joint Surg (Am), 2017, 99(24): 2053-2061.
|
23. |
Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res, 2014, 8(1): 48-53.
|
24. |
Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The safety of tranexamic acid in total joint arthroplasty: A direct meta-analysis. J Arthroplasty, 2018, 33(10): 3070-3082.
|
25. |
Kim YT, Kang MW, Lee JK, et al. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. BMC Musculoskelet Disord, 2018, 19(1): 227.
|
26. |
Jansen JA, Lameijer JRC, Snoeker BAM. Combined intravenous, topical and oral tranexamic acid administration in total knee replacement: Evaluation of safety in patients with previous thromboembolism and effect on hemoglobin level and transfusion rate. Knee, 2017, 24(5): 1206-1212.
|
27. |
Heller S, Secrist E, Shahi A, et al. Tranexamic acid can be administered to arthroplasty patients who receive aspirin for venous thromboembolic prophylaxis. J Arthroplasty, 2016, 31(7): 1437-1441.
|